Data on Type 2 Diabetes Reported by Xiangjin Xu and Colleagues (Efficacy and safety of linagliptin as add-on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial)

Source :: Obesity, Fitness & Wellness Week. November 21, 2020, 102
Publication Year :: 2020
Abstract: 2020 NOV 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Nutritional and Metabolic Diseases and Conditions - Type 2 [...]

Subjects :: Clinical trials -- Reports -- Research
Physical fitness -- Research -- Reports
Linagliptin -- Research
Type 2 diabetes -- Research -- Care and treatment
Medical research -- Reports
Diabetes therapy -- Product development
Glycosylated hemoglobin -- Reports -- Research
Insulin -- Research -- Product development
Health

Tools